Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2002 Dec;61(12):1055–1059. doi: 10.1136/ard.61.12.1055

Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage

E Lindqvist 1, T Saxne 1, P Geborek 1, K Eberhardt 1
PMCID: PMC1753974  PMID: 12429534

Abstract

Objective: To investigate outcome as measured by health status, disease process, and damage in an unselected group of patients with early rheumatoid arthritis (RA) monitored prospectively for 10 years and to search for prognostic factors.

Patients and methods: 183 patients with RA with disease duration <2 years were assessed annually at a team care unit. Health status was measured by the Health Assessment Questionnaire (HAQ) and functional class. Disease process was assessed by clinical and laboratory measures of disease activity and evaluation of disease course. Damage was quantified as occurrence of major extra-articular manifestations and need for large joint replacements. Possible predictive factors were evaluated by logistic regression analyses.

Results: 168/183 patients completed the entire follow up period. Of all 183 patients, 137 (75%) had been treated with disease modifying antirheumatic drugs and 84 (46%) with low dose oral glucocorticoids. After 10 years 158 patients (94%) managed daily life activities independently (functional class I–II). As measured by the HAQ 20% had almost no disability, 28% were mildly disabled, and 10% were seriously disabled. Median HAQ score had increased from 0.8 to 1.1 (p<0.001). Disease activity was significantly reduced. 133 patients (79%) had a relapsing remitting disease course and 30 patients (18%) were in remission as defined by the American College of Rheumatology criteria. Thirty patients (17%) had undergone large joint replacements. Fifteen patients (8%) had developed major extra-articular complications. The HAQ score during the first three months predicted disability at 10 years with an odds ratio of 13.4.

Conclusions: Prospective studies such as this give important knowledge of the variable long term prognosis of RA and provide necessary background information for clinical trials of new treatment modalities.

Full Text

The Full Text of this article is available as a PDF (149.5 KB).

Figure 1 .

Figure 1

Open in a new tab

Functional class distribution according to Steinbrocker at study start and years 1, 5, and 10.

Figure 2 .

Figure 2

Open in a new tab

HAQ and VAS pain at the study start and years 1, 5, and 10. The box plots show the median and 10th, 25th, 75th, and 90th centiles.

Figure 3 .

Figure 3

Open in a new tab

Distribution of HAQ scores after 10 years.

Figure 4 .

Figure 4

Open in a new tab

Active joint count and ESR at the study start and years 1, 5, and 10. The box plots show the median and 10th, 25th, 75th, and 90th centiles.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corbett M., Dalton S., Young A., Silman A., Shipley M. Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years. Br J Rheumatol. 1993 Aug;32(8):717–723. doi: 10.1093/rheumatology/32.8.717. [DOI] [PubMed] [Google Scholar]
  2. Drossaers-Bakker K. W., de Buck M., van Zeben D., Zwinderman A. H., Breedveld F. C., Hazes J. M. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum. 1999 Sep;42(9):1854–1860. doi: 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  3. Eberhardt K. B., Fex E. Functional impairment and disability in early rheumatoid arthritis--development over 5 years. J Rheumatol. 1995 Jun;22(6):1037–1042. [PubMed] [Google Scholar]
  4. Eberhardt K. B., Rydgren L. C., Pettersson H., Wollheim F. A. Early rheumatoid arthritis--onset, course, and outcome over 2 years. Rheumatol Int. 1990;10(4):135–142. doi: 10.1007/BF02274837. [DOI] [PubMed] [Google Scholar]
  5. Eberhardt K., Fex E. Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years. Br J Rheumatol. 1998 Dec;37(12):1324–1329. doi: 10.1093/rheumatology/37.12.1324. [DOI] [PubMed] [Google Scholar]
  6. Eberhardt K., Fex E., Johnson U., Wollheim F. A. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis. 1996 Jan;55(1):34–39. doi: 10.1136/ard.55.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ekdahl C., Eberhardt K., Andersson S. I., Svensson B. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol. 1988;17(4):263–271. doi: 10.3109/03009748809098795. [DOI] [PubMed] [Google Scholar]
  8. Fex E., Larsson B. M., Nived K., Eberhardt K. Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol. 1998 Jan;25(1):44–50. [PubMed] [Google Scholar]
  9. Isomäki H. Long-term outcome of rheumatoid arthritis. Scand J Rheumatol Suppl. 1992;95:3–8. doi: 10.3109/03009749209101477. [DOI] [PubMed] [Google Scholar]
  10. Jacoby R. K., Jayson M. I., Cosh J. A. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up. Br Med J. 1973 Apr 14;2(5858):96–100. doi: 10.1136/bmj.2.5858.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lindqvist E., Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis. 1999 Jan;58(1):11–14. doi: 10.1136/ard.58.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Möttönen T., Paimela L., Ahonen J., Helve T., Hannonen P., Leirisalo-Repo M. Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum. 1996 Jun;39(6):996–1005. doi: 10.1002/art.1780390617. [DOI] [PubMed] [Google Scholar]
  13. Pinals R. S., Baum J., Bland J., Fosdick W. M., Kaplan S. B., Masi A. T., Mitchell D. M., Ropes M. W., Short C. L., Sigler J. W. Preliminary criteria for clinical remission in rheumatoid arthritis. Bull Rheum Dis. 1982;32(1):7–10. [PubMed] [Google Scholar]
  14. Pincus T., Callahan L. F., Sale W. G., Brooks A. L., Payne L. E., Vaughn W. K. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984 Aug;27(8):864–872. doi: 10.1002/art.1780270805. [DOI] [PubMed] [Google Scholar]
  15. Prevoo M. L., van Gestel A. M., van T Hof M. A., van Rijswijk M. H., van de Putte L. B., van Riel P. L. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol. 1996 Nov;35(11):1101–1105. doi: 10.1093/rheumatology/35.11.1101. [DOI] [PubMed] [Google Scholar]
  16. Rasker J. J., Cosh J. A. The natural history of rheumatoid arthritis over 20 years. Clinical symptoms, radiological signs, treatment, mortality and prognostic significance of early features. Clin Rheumatol. 1987 Sep;6 (Suppl 2):5–11. doi: 10.1007/BF02203379. [DOI] [PubMed] [Google Scholar]
  17. Scott D. L., Spector T. D., Pullar T., McConkey B. What should we hope to achieve when treating rheumatoid arthritis? Ann Rheum Dis. 1989 Mar;48(3):256–261. doi: 10.1136/ard.48.3.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sherrer Y. S., Bloch D. A., Mitchell D. M., Young D. Y., Fries J. F. The development of disability in rheumatoid arthritis. Arthritis Rheum. 1986 Apr;29(4):494–500. doi: 10.1002/art.1780290406. [DOI] [PubMed] [Google Scholar]
  19. Spector T. D. Epidemiological aspects of studying outcome in rheumatoid arthritis. Br J Rheumatol. 1988;27 (Suppl 1):5–11. [PubMed] [Google Scholar]
  20. Truedsson L., Sjöholm A. G., Sturfelt G. Complement activating rheumatoid factors in rheumatoid arthritis studied by haemolysis in gel: relation to antibody class and response to treatment with podophyllotoxin derivatives. Clin Exp Rheumatol. 1985 Jan-Mar;3(1):29–37. [PubMed] [Google Scholar]
  21. Turesson C., Jacobsson L., Bergström U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 1999 Jul;38(7):668–674. doi: 10.1093/rheumatology/38.7.668. [DOI] [PubMed] [Google Scholar]
  22. Watts R. A., Carruthers D. M., Symmons D. P., Scott D. G. The incidence of rheumatoid vasculitis in the Norwich Health Authority. Br J Rheumatol. 1994 Sep;33(9):832–833. doi: 10.1093/rheumatology/33.9.832. [DOI] [PubMed] [Google Scholar]
  23. Wolfe F., Hawley D. J., Cathey M. A. Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis. J Rheumatol. 1991 Sep;18(9):1290–1297. [PubMed] [Google Scholar]
  24. Wolfe F., Hawley D. J. Remission in rheumatoid arthritis. J Rheumatol. 1985 Apr;12(2):245–252. [PubMed] [Google Scholar]
  25. Wolfe F., Kleinheksel S. M., Cathey M. A., Hawley D. J., Spitz P. W., Fries J. F. The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol. 1988 Oct;15(10):1480–1488. [PubMed] [Google Scholar]
  26. Wolfe F., Lassere M., van der Heijde D., Stucki G., Suarez-Almazor M., Pincus T., Eberhardt K., Kvien T. K., Symmons D., Silman A. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol. 1999 Feb;26(2):484–489. [PubMed] [Google Scholar]
  27. Wolfe F., Zwillich S. H. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum. 1998 Jun;41(6):1072–1082. doi: 10.1002/1529-0131(199806)41:6<1072::AID-ART14>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  28. Young A., Dixey J., Cox N., Davies P., Devlin J., Emery P., Gallivan S., Gough A., James D., Prouse P. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS) Rheumatology (Oxford) 2000 Jun;39(6):603–611. doi: 10.1093/rheumatology/39.6.603. [DOI] [PubMed] [Google Scholar]
  29. van Zeben D., Hazes J. M., Zwinderman A. H., Vandenbroucke J. P., Breedveld F. C. Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol. 1993 Aug;20(8):1288–1296. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES